ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Conference Abstract - POSTER

SJEMed. 2024; 5(1): S31-S31


Severe Digoxin Toxicity in a Child Managed with Cholestyramine. A Case Report

Suman Noorani, Nadeem ullah Khan, Shahan Waheed, Hadia Iftikhar.



Abstract
Download PDF Post

Digoxin toxicity is a common problem in clinical practice because its therapeutic window is relatively narrow (from 0.5 to 2 ng/ml). The toxic effects occur at concentrations > 2.8 ng/ml and are mainly related to disturbances of cardiac function and of circulatory system as well as GI and CNS disturbances. We report a case of digoxin toxicity in a 2.5years old male child who accidently ingested 15 tablets of digoxin x 0.25mg. During his stay in pediatric ICU, typical symptoms of toxicity were observed.
Digoxin-specific antibody (Fab) fragments have become the mainstay of treatment in severe digoxin toxicity. However, due to its high cost and limited availability, alternative measures are used to manage severe intoxications in countries like Pakistan, where Fab fragments are not available. Here we successfully treated severe digoxin intoxication with Cholestyramine.

Key words: Digoxin toxicity, cholestyramine, substance abuse.







Bibliomed Article Statistics

27
17
22
19
22
32
23
18
22
18
20
7
R
E
A
D
S

12

14

15

10

8

10

5

11

6

20

6

3
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.